These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37965902)

  • 21. The comparison of in the vitro effect of imipenem or meropenem combined with ciprofloxacin or levofloxacin against multidrug-resistant Pseudomonas aeruginosa strains.
    Erdem I; Kaynar-Tascioglu J; Kaya B; Goktas P
    Int J Antimicrob Agents; 2002 Nov; 20(5):384-6. PubMed ID: 12431875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potent activity of meropenem against Escherichia coli arising from its simultaneous binding to penicillin-binding proteins 2 and 3.
    Sumita Y; Fukasawa M
    J Antimicrob Chemother; 1995 Jul; 36(1):53-64. PubMed ID: 8537284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial activity of doripenem against Gram-negative pathogens: results from INVITA-A-DORI Brazilian study.
    Gales AC; Azevedo HD; Cereda RF; Girardello R; Xavier DE;
    Braz J Infect Dis; 2011; 15(6):513-20. PubMed ID: 22218508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of meropenem (SM-7338), imipenem, and five other antibiotics against anaerobic clinical isolates.
    Murray PR; Niles AC
    Diagn Microbiol Infect Dis; 1990; 13(1):57-61. PubMed ID: 2331851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meropenem and imipenem activity against Pseudomonas aeruginosa isolates from the MYSTIC Program.
    Turner PJ
    Diagn Microbiol Infect Dis; 2006 Nov; 56(3):341-4. PubMed ID: 17049798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meropenem resistance in imipenem-susceptible meropenem-resistant Klebsiella pneumoniae isolates not detected by rapid automated testing systems.
    Harino T; Kayama S; Kuwahara R; Kashiyama S; Shigemoto N; Onodera M; Yokozaki M; Ohge H; Sugai M
    J Clin Microbiol; 2013 Aug; 51(8):2735-8. PubMed ID: 23720796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of polymyxin B plus imipenem, meropenem, or tigecycline against KPC-2-producing Enterobacteriaceae with high MICs for these antimicrobials.
    Barth N; Ribeiro VB; Zavascki AP
    Antimicrob Agents Chemother; 2015; 59(6):3596-7. PubMed ID: 25801560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formulation of carbapenems loaded gold nanoparticles to combat multi-antibiotic bacterial resistance: In vitro antibacterial study.
    Shaker MA; Shaaban MI
    Int J Pharm; 2017 Jun; 525(1):71-84. PubMed ID: 28411141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility of important Gram-negative pathogens to tigecycline and other antibiotics in Latin America between 2004 and 2010.
    Fernández-Canigia L; Dowzicky MJ
    Ann Clin Microbiol Antimicrob; 2012 Oct; 11():29. PubMed ID: 23088592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative in vitro activity of biapenem, a new carbapenem antibiotic.
    Clarke AM; Zemcov SJ
    Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):377-84. PubMed ID: 8354306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of meropenem and four other antibiotics against 554 clinical strains obtained from Beijing in 1999.
    Wang H; Chen M; Xie X; Xu Y; Zhang X; Zhang Y; Yuan Y; Wang C; Liu J; Wang P
    J Infect Chemother; 2000 Sep; 6(3):178-83. PubMed ID: 11810561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging resistance to carbapenems in a tertiary care hospital in north India.
    Gupta E; Mohanty S; Sood S; Dhawan B; Das BK; Kapil A
    Indian J Med Res; 2006 Jul; 124(1):95-8. PubMed ID: 16926463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In-vitro activity of meropenem against clinical isolates obtained in Canada.
    Clarke AM; Zemcov SJ
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():47-55. PubMed ID: 2808216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro and in vivo antibacterial activities of meropenem, a new carbapenem antibiotic.
    Harabe E; Kawai Y; Kanazawa K; Otsuki M; Nishino T
    Drugs Exp Clin Res; 1992; 18(2):37-46. PubMed ID: 1644010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activities of three carbapenems against recent bacterial isolates from severely ill patients at Swedish hospitals.
    Fraenkel CJ; Ullberg M; Bernander S; Ericson E; Larsson P; Rydberg J; Törnqvist E; Melhus A
    Scand J Infect Dis; 2006; 38(10):853-9. PubMed ID: 17008228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic-induced release of endotoxin: in-vitro comparison of meropenem and other antibiotics.
    Trautmann M; Zick R; Rukavina T; Cross AS; Marre R
    J Antimicrob Chemother; 1998 Feb; 41(2):163-9. PubMed ID: 9533457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity and killing effect of DX-8739, a new carbapenem, compared with those of meropenem and imipenem against multiresistant Pseudomonas aeruginosa.
    Giamarellos-Bourboulis EJ; Grecka P; Giamarellou H
    Antimicrob Agents Chemother; 1995 Mar; 39(3):731-4. PubMed ID: 7793881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative evaluation of in vitro activities of carbapenems against gram-negative pathogens: Turkish data of COMPACT study].
    Korten V; Söyletir G; Yalçın AN; Oğünç D; Dokuzoğuz B; Esener H; Ulusoy S; Tünger A; Aygen B; Sümerkan B; Arman D; Dizbay M; Akova M; Hasçelik G; Eraksoy H; Başaran S; Köksal I; Bayramoğlu G; Akalın H; Sınırtaş M
    Mikrobiyol Bul; 2011 Apr; 45(2):197-209. PubMed ID: 21644063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the vitek 2 AST-N269 card for detection of meropenem resistance in imipenem-susceptible meropenem-resistant Enterobacteriaceae.
    Koizumi A; Kasahara K; Komatsu Y; Ui K; Mizuno F; Nakayama A; Mikasa K
    J Clin Microbiol; 2013 Nov; 51(11):3908. PubMed ID: 23966492
    [No Abstract]   [Full Text] [Related]  

  • 40. In-vitro activity of new carbapenem antibiotics: comparative studies with meropenem, L-627 and imipenem against pathogenic Nocardia spp.
    Yazawa K; Mikami Y; Ohashi S; Miyaji M; Ichihara Y; Nishimura C
    J Antimicrob Chemother; 1992 Feb; 29(2):169-72. PubMed ID: 1506332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.